N-(Hetero)aryl-2-imidazolines: an emerging privileged motif for contemporary drug design
Crossref DOI link: https://doi.org/10.1007/s10593-017-2047-3
Published Online: 2017-04-26
Published Print: 2017-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Krasavin, Mikhail
License valid from 2017-03-01